Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 256 pseudogene 2 (TMEM256P2) is a pseudogene, meaning it is a segment of DNA that represents a nonfunctional remnant of a gene that once encoded a protein. Pseudogenes arise through gene duplication or retrotransposition, then accumulate mutations that prevent them from producing a functional protein. TMEM256P2 is annotated in genomic resources as a non-coding locus with no evidence of protein expression and no known biological or therapeutic relevance[1][2][4]. There is no evidence from the literature that TMEM256P2 encodes a receptor, enzyme, transporter, or has any molecular activity or disease association. TMEM256P2 does not appear in major databases of therapeutic targets and is not associated with any drugs or considered a clinical or research biomarker. For further research, it should be noted this is not a valid target in pharmaceutical research or molecular medicine[1]. Summary of core issues: - TMEM256P2 is a pseudogene, not a functional protein, enzyme, transporter, or receptor[1]. - It is not a drug target, nor is there evidence for interaction with any drugs. - There are no known biological functions, disease roles, or therapeutic mechanisms associated with TMEM256P2. - is_incorrect: true because it is not a valid target for therapeutics, and it represents a common error seen when extracting names from gene/pseudogene lists without functional validation. References: [1] GeneCards entry for TMEM256P2 classifies it solely as a pseudogene, with no protein product or known function. [2][4] General literature on pseudogenes confirms their usual lack of protein-coding function and highlights that only rarely are pseudogenes biologically relevant, usually through RNA-based regulatory functions—none are described for TMEM256P2. If you require structured information for a real transmembrane protein receptor target, please specify the correct gene or protein name.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 256 pseudogene 2 (TMEM256P2).